AD
Andrews Deborah J
董事
BoardF
内部人交易记录
董事尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Andrews Deborah J, 董事. Director active across 2 companies, notably Lineage Cell Therapeutics, Inc.. Cumulatively, 11 filings have been published. Activity tracked since 29 June 2021. The latest transaction was disclosed on 14 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Andrews Deborah J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
5,233 股0Common StockSEC:0001325697-26-000011:0
2,662 股@ US$26.18Common StockSEC:0001325697-26-000011:1
13,955 股Common StockSEC:0001325697-26-000009:0
20,787 股Common StockSEC:0001325697-26-000009:2
10,576 股@ US$24.360.021% mcap40.2% 占其流量Common StockSEC:0001325697-26-000009:3
6,480 股@ US$31.210.017% mcap32.0% 占其流量Common StockSEC:0001325697-26-000009:1
1,877 股@ US$32.070.0045% mcap33.3% 占其流量Common StockSEC:0001325697-26-000006:3
3,755 股@ US$32.070.0091% mcap66.7% 占其流量Common StockSEC:0001325697-26-000006:1
10,466 股0Common StockSEC:0001325697-26-000006:0
5,233 股0Common StockSEC:0001325697-26-000006:2
24,720 股@ US$2.20100.0% 占其流量Common Shares, no par valueSEC:0001493152-21-015788:0
About Andrews Deborah J
ANDREWS DEBORAH J is Administrateur and has 9 filings in total. In the 9 recent filings available, the amounts reported are related to tax withholding, with transactions at Staar Surgical Co and Lineage Cell Therapeutics, Inc., between 2021-06-30 and 2026-08-04.